Canaccord initiated coverage of Amgen (AMGN) with a Hold rating and $366 price target
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMGN:
- Kailera Stock (KLRA) Rockets 68% after IPO in Race for $150B Obesity Market
- OpenAI Debuts GPT-Rosalind, Its First AI Model Built Exclusively for Scientists
- OpenAI Launches New AI Model to Speed Up Drug Discovery
- Trump names Erica Schwartz CDC Director
- Private Markets: Slate Auto, Plata land major rounds